A stubborn behaviour: The failure of antidepressants to reduce suicide rates

World Journal of Biological Psychiatry

Volumn 4, Issue 4, 2003, Pages 184-191

  Van Praag, Herman M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

antidepressants; depression; psychotherapy; suicide rate; suicide research

Indexed keywords

EID: 1542273812     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970310029917     Document Type: Article

References (67)

1. Agosti V, Steward JW, Quitkin FM, Ocepek-Welikson K (1993) How symptomatic do depressed patients remain after benefiting from medication treatment? Compr Psychiatry 34:182-186.
2. Beasly CM, Dornseif BE, Bosomworth JC, Sayler ME, Rampey AH (1991) Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Br Med J 303:685-692.
3. Blier P, De Montigny C (1994) Current advances and trends in the treatment of depression. TIPS 15:220-226.
4. Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C (1999) Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry 174:297-303.
5. Bostwick JM, Pankratz VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157:1925-1932.
6. Byrne SE, Rothschild AJ (1998) Loss of antidepressant efficacy during maintenance therapy. J Clin Psychiat 59:279-288.
7. Clayton PJ, Trust C, Angst J (1994) Premorbid personality traits of men who develop unipolar or bipolar disorders. Eur Arch Psychiat Clin Neurosci 243:340-346.
8. Coccaro EF, Kavoussi RY (1997) Fluoxetine and impulsive aggressive behavior in personality - disordered subjects. Arch Gen Psychiatry 54:1081-1088.
9. Damluji NF, Ferguson JM (1988) Paradoxical worsening of depressive symptomatology caused by antidepressants. J Clin Psychopharmacology 8:347-349.
10. De Leo D, Evans R (2002) Suicide in Queensland 1996-1998: mortality rates and related data. Australian Institute of Suicide Research and Prevention (AISRAP), Griffith University.
11. Diekstra RFW (1995) The epidemiology of suicide and parasuicide. In: Diekstra RFW, Galbinat W, Kienhorst I, DeLeo D (eds) Preventive strategies in suicide. EYJ Brill, Leiden.
12. Druss BG, Hoff RA, Rosenheck RA (2000) Underuse of antidepressants in major depression: prevalence and correlates in a national sample of young adults. J Clin Psychiat 61:234-237.
13. Faravelli C, Ambonetti A, Pallanti S, Pazzagli A (1986) Depressive relapse and incomplete recovery from index episode. Am J Psychiatry 143:888-891.
14. Fava GA (1999) Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 29:47-61.
15. Fava M, Rosenbaum JF (1991) Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry 52:108-111.
16. Goodwin FK, Jamison KR (1990) Manic-depressive Illness. New York, Oxford University Press.
17. Gunnell D, Lopatatzidis A, Dorling D, Wehner H, Southall H, Frankel S (1999) Suicide, unemployment and gender analysis of trends in England and Wales 1921-1995. Br J Psychiatry 175:263-270.
18. Gunnell D, Shepherd M, Evans M (2000) Are recent increases in deliberate self-harm associated with changes in socio-economic conditions? An ecological analysis of patterns of deliberate selfharm in Bristol 1972-3 and 1995-6. Psychol Med 30:1197-1203.
19. Guze SB, Robins E (1970) Suicide and primary affective disorders. Br J Psychiatry 117:437-438.
20. Hawton K, Fagg J, Simkin S, Bale E (1997) Bond A. Trends in deliberate self-harm in Oxford, 1985-1995. Br J Psychiatry 171:556-560.
21. Healy D (1994) The fluoxetine and suicide controversy. CNS Drugs 1:223-231.
22. Healy D (2000) Antidepressant induced suicidality. Prim Care Psychiatry 6:23-28.
23. Heiligenstein JH, Tollefson GD, Faries DE (1994) Response patterns of depressed outpatients with and without melancholia: a doubleblind, placebo-controlled trial of fluoxetine versus placebo. J Affect Disord 30:163-173.
24. Hirschfeld RM, Klerman GL, Clayton PJ, Keller MB (1983) Personality and depression. Empirical findings. Arch Gen Psychiatry 40:993-998.
25. Isacsson J, Bergman U, Rich CL (1996) Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 41:1-8.
26. Isacsson J, Holmgren P, Druid H, Bergman U (1997) The utilization of antidepressants: a key issue in the prevention of suicide. Acta Psychiat Scandinavica 96:94-100.
27. Isometsä ET, Lönnqvist JK (1998) Suicide attempts preceding completed suicide. Br J Psychiatry 173:531-535.
28. Kasper S, Schindler S, Neumeister A (1996) Risk of suicide in depression and its implication for psychopharmacological treatment. Int Clin Psychopharmacol 11:71-79.
29. Kerkhof AJFM (2000) Attempted suicide: patterns and trends. In: Hawton K, Van Heeringen K (eds) The international handbook of suicide and attempted suicide. John Wiley, Chichester.
30. Khan A, Warner HA, Brown WA (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration Database. Arch Gen Psychiatry 57:311-317.
31. Khan A, Khan SR, Leventhal RM, Brown WA (2001) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. Intern J Neuropsychopharmacology 4:113-118.
32. Lecrubier Y (1998) Is depression under-recognised and undertreated? Int Clin Psychopharmacol 13:3S-6S.
33. Leon AC, Keller MB, Warshaw MG, Mueller TI, Solomon DA, Coryell W, Endicott J (1999) Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am J Psychiat 156:195-201.
34. Lester D, Yang B (1998) Suicide and homicide in the twentieth century; changes over time. Nova Science, Commack, N. Y
35. Malone KM, Moran M (2001) Psychopharmacological approaches to the suicidal process. In: Van Heeringen K (ed) Understanding suicidal behavior. The suicidal process. Approach to research, treatment and prevention. John Wily, Chichester, UK.
36. Mann JJ, Kapur S (1991) The emergence of suicidal ideation and behaviour during antidepressant pharmacotherapy. Arch Gen Psychiat 48:1027-1033.
37. Mann JJ, Waternaux C, Haas GL, Maone KM (1999) Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 156:181-189.
38. McClure GMG (2000) Changes in suicide in England and Wales, 1960-1997. Br J Psychiat 176:64-67.
39. Myin-Germeys I, Van Os J, Schwartz JE, Stone AA, Delespaul Ph A (2001) Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 58:1137-1144.
40. Montgomery SA, Dunner, DL, Dunbar, GC (1995) Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharm 5:5-13.
41. Montgomery SA (1997) Suicide and antidepressants. Ann N. Y. Acad Sci 836:329-338.
42. Moscicki E (1998) Epidemiology of suicide behavior. Suicide and Life-Threatening. Behavior 25:22-35.
43. Müller-Oerlinghausen B, Müser-Causemann B, Volk J (1992) Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 25:261-270.
44. Müller-Oerlinghausen B, Berghöfer A (1999) Antidepressants and suicidal risk. J Clin Psychiat 60:94-99.
45. O'Leary D, Costello F (2001) Personality and outcome in depression: an 18-month prospective follow-up study. J Affect Disord 63:67-78.
46. Olivier B, Mos J (1992) Rodent models of aggressive behaviour and serotonergic drugs. Progress Neuropsychopharm Biol Psychiatry 16:847-870.
47. Oquendo MA, Kamali M, Ellis SP, Grunebaum MF, Malone KM, Brodsky BS, Sackeim HA, Mann JJ (2002) Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study. Am J Psychiat 159:1746-1751.
48. Pihlgren H (1995) Depression and suicide on Gotland. An intensive study of all suicides before and after a depressiontraining programme for general practitioners. J Affect Disord 35:147-152.
49. Platt S, Hawton K (2000) Suicidal behaviour and the labour market. In: Hawton K, Van Heeringen K (Eds) The international handbook of suicide and attempted suicide. John Wiley, Chichester.
50. Rihmer Z (2001) Can better recognition and treatment of depression reduce suicide rates? A brief review. Eur Psychiat 16:406-409.
51. Roth U (2001) Unitary or binary nature of classification of depressive illness and its implications for the scope of manic depressive disorder. J Affect Disord 64:1-18.
52. Roy A (2001) Psychiatric treatment and suicide prevention. In: Lester D (ed) Suicide prevention. Resources for the millenium. Brunner-Routledge, Philadelphia, pp 103-128.
53. Rutz W, Walinder J, Eberhard G, Holmberg G, Von Knorring A-L, Wistedt B, Aberg-Wistedt A (1989) An educational program on depressive disorders for general practitioners on Gotland: background and evaluation. Acta Psychiat Scand 79:19-26.
54. Sonino N, Fava GA (2002) Residual symptoms in depression: an emerging therapeutic concept. Progress in Neuro-Psychopharmacol Biol Psychiat 26:763-770.
55. Storosum JG, Van Zwieten BJ, Van den Brink W, Gersons BPR, Broekmans AW (2001) Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 158:1271-1275.
56. Teicher MH, Glod C, Cole JO (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147:207-210.
57. Tondo L, Jamison KR, Baldessarini, RJ (1997) Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N. Y. Acad Sci 836:339-351.
58. Van Eck M, Nicolson NA, Berkhof J (1998) Effects of stressful daily events on mood states: relationship to global perceived stress. J Pers Suicidal Psychology 75:1572-1585.
59. Van Praag HM (1962) A critical investigation into the significance of monoamineoxydase inhibition as a therapeutic principle in the treatment of depression. Thesis, Utrecht.
60. Van Praag HM (1978) Psychotropic drugs. A guide for the practitioner. Brunner/Mazel, New York.
61. Van Praag HM (1992) Reconquest of the subjective. Against the waning of psychiatric diagnosing. Br J Psychiatry 160:266-271.
62. Van Praag HM (1997) Over the mainstream: diagnostic requirements for biological psychiatric research. Psychiatry Res 72:201-212.
63. Van Praag HM (2000) Nosologomania: a disorder of psychiatry. World J Biol Psychiatry 2:151-158.
64. Van Praag HM, Van Os J, De Kloet D (In Press) Stress, the brain and depression. Can stress cause depression? Cambridge University Press.
65. Verkes RJ, Van der Mast RC, Hengeveld W, Tuyl JP, Zwinderman AH, Van Kempen GM (1998) Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Am J Psychiatry 155:543-547.
66. Walsh M-T, Dinan TG (2001) Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiat Scand 104:84-91.
67. Wasserman D (Ed.) (2000) Suicide. An unnecessary death. Martin Dunitz, London.